Naveed Siddiqi

Senior Partner

2021 - Current

Naveed is a member of Ventures Investment leadership team. Naveed is also a member of the Investment Committee for Novo Holdings Asia PTE.

Partner

2019

Novo Holdings is a company wholly owned by the Novo Nordisk Foundation. It is the holding and investment company of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the Novo Nordisk Foundation’s assets. Novo Holdings is recognized as a one of the world's largest international life science investors, with a focus on creating long- term value. Novo Holdings provides seed and venture capital to development- stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings manages $13 billion of life science investments.

Board Member

2024

Board Member

2023

Board Observer

2021

LP Advisory Committee Member

2021

Board Member

2020

Board Member

2020 - 2024

Board Member

2021 - 2022

Board Member

2020 - 2021

Partner

2013 - 2018

Partner - life sciences at Andera Partners (formerly Edmond de Rothschild Investment Partners). The life sciences team of Andera Partners is a highly experienced and leading investor in therapeutic and medical technology companies. Andera Partners has over €2bn under management across European growth equity and global life sciences.